China’s National Medical Products Administration has approved a first-in-class drug targeting type 1 narcolepsy in adults and adolescents 16 and older.
The drug, which improves symptoms of excessive daytime sleepiness and cataplexy, marks a breakthrough for a globally innovative drug launched first in China. It has also been filed in the U.S., Japan and Europe.
News summary
China will allocate 22 billion yuan ($3.3 billion) in ultra-long-term special treasury bonds to support the scrapping and replacement of old commercial freight vehicles, with a focus on upgrading to new-energy heavy trucks.
China plans to build more than 3,000 charging and battery-swapping stations for electric heavy trucks.
A Tencent Cloud executive said that enterprises will widely deploy domestic computing capacity to sharply cut AI inference costs.
Anthropic agreed to a $1.5 billion settlement in a lawsuit brought by authors, setting a record for copyright damages in the U.S.
Contact editor Lin Jinbing (jinbinglin@caixin.com)
